EUCTR2007-001646-40-DE进行中（未招募）1 期
A Phase III Open-Label, Single-Group Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients - MICONOS EXTENSIO
Santhera Pharmaceuticals (Switzerland) Limited0 个研究点目标入组 232 人开始时间: 2007年4月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 232
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Completion of 52 weeks in study SNT-III-001
- •Body weight = 25kg
- •Negative urine pregnancy test
- •Eligibility to participate in the present extension study as confirmed by the investigator
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Safety or tolerability issues arising during the course of SNT-III-001 which in the
- •opinion of the investigator preclude further treatment with idebenone
- •Clinically significant abnormalities of haematology or biochemistry including, but
- •not limited to, elevations greater than 1.5 times the upper limit of SGOT, SGPT or
- •Parallel participation in another clinical drug trial
- •Pregnancy or breast-feeding
- •Abuse of drugs or alcohol
研究者
相似试验
进行中（未招募）
不适用
A Phase III Open-Label, Single-Group Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients - MICONOS EXTENSIOFriedreich's AtaxiaEUCTR2007-001646-40-NLSanthera Pharmaceuticals (Switzerland) Ltd204
进行中（未招募）
1 期
A Phase III Open-Label, Single-Group Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients - MICONOS EXTENSIOEUCTR2007-001646-40-BESanthera Pharmaceuticals (Switzerland) Ltd232
进行中（未招募）
1 期
A Phase III Open-Label, Single-Group Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients - MICONOS EXTENSIOEUCTR2007-001646-40-FRSanthera Pharmaceuticals (Switzerland) Ltd204
进行中（未招募）
不适用
A Phase III Open-Label, Single-Group Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients - MICONOS EXTENSIOFriedrich's AtaxiaMedDRA version: 12.0Level: LLTClassification code 10017374Term: Friedreich's ataxiaEUCTR2007-001646-40-ATSanthera Pharmaceuticals (Switzerland) Ltd232
进行中（未招募）
1 期
The study to test whether patients can tell if they feel better when they are treated with IdebenoneEUCTR2007-001646-40-GBSanthera Pharmaceuticals (Switzerland) Ltd232